Since IFN-α subset levels are likely to vary among patients with SLE and over time, it is expected that similar circulating amounts of total IFN-α will have variable activities according to the proportion of IFNs with low, intermediate, and high activity. The gene discussed is IFNA2; the disease is systemic lupus erythematosus.